Global Vaccine Data Network

The GVDN™, a multinational, investigator-led network, was founded in 2019 with 21 partner sites across 17 countries. They now have 23 partners across 19 countries, representing more than 250 million people, and continue to expand. They aim to evaluate vaccine safety concerns through analysis and evaluation of large clinical databases, focusing on rare events, evaluate vaccine effectiveness to facilitate risk/benefit analyses, and coordinate response to concerns regarding vaccines, such as vaccine hesitancy.

VAC4EU is an active member of the GVDN network. We also serve as the coordinating centre for all European sites in the Global Vaccine Safety Project (GCoVS), led by GVDN. This study aims to evaluate the safety of COVID-19 vaccines in 26 countries, leveraging the diverse populations covered in the GVDN consortium. In addition, we are regular contributors to their biannual newsletter, entitled Safety by Numbers. The purpose of this newsletter is to highlight collaboration and share data and resources to support vaccine safety communication.